← AlphaSignal

Notes

Top 5 Undervalued US Common Stocks with Improving Fundamentals (October 24, 2026)

2026-10-24Screening report

Data as of 2026-10-24US market

Summary

Screened 12 undervalued US stocks on October 24, 2026; ADBE, PYPL, NKE, CVS, and LEN offer the strongest fundamental resilience, margin expansion, and valuation discounts for a 6 to 18 month horizon.

Screening weights

Fundamental improvement30%
Valuation25%
Balance sheet15%
Catalysts15%
Price dislocation10%
Risk5%

Candidate comparison

RankTickerSector3M returnRevenue YoYOPM ΔFCFScore
1
Adobe Inc.
Software-18.8%+10.6%+1.5%pPositive9.6
2
PayPal Holdings
Fintech-7.8%+8.2%+1.1%pPositive9.3
3
NIKE, Inc.
Consumer-14.8%+1.1%+0.4%pPositive9.1
4
CVS Health
Healthcare-6.2%+7.3%+1.0%pPositive8.8
5
Lennar Corporation
Homebuilding-12.1%+7.9%+0.2%pPositive8.7
6
Autodesk
Design Software-3.2%+16.0%+2.0%pPositive8.5
7
Western Digital
Storage Hardware-5.8%+23.8%+4.3%pPositive8.4
8
Lululemon Athletica
Consumer-18.5%+7.3%+0.4%pPositive8.2
9
Salesforce
Cloud CRM-10.2%+8.4%+3.2%pPositive8.0
10
J.B. Hunt Transport
Industrials-11.8%+4.8%+0.3%pPositive7.8
11
Starbucks
Restaurants-3.2%+2.2%+0.4%pPositive7.5
12
Intel
Semiconductors-13.5%+7.5%+0.6%pPositive6.5

Screened names (observations)

ADBEAdobe Inc.

Score: 9.6

Open ticker →

Observation

Exceptional valuation and cash-flow disconnect at $240-$245 multi-year lows, down 46% off peak as Treasury yield surges pressure tech multiples. Trades at an EV/FCF of ~10.0x (lower than 99% of its 10-year trading range). Generates $2.2B+ in quarterly free cash flow ($8B+ annual run-rate) with 46% Non-GAAP operating margin and $25B active share repurchases retiring 29M shares YoY.

Catalysts to watch

  • Commercial adoption of next-gen Firefly video models and enterprise GenStudio post-Adobe MAX
  • Oversold technical mean-reversion toward 20-day moving average
  • Aggressive multi-billion dollar open-market share repurchases

Risks

  • Generative AI design pricing competition
  • Enterprise creative sales cycle elongation

Framework exit signals

  • Digital Media net new ARR growth falls below +8% YoY
  • GAAP operating margin contracts below 32%

Metrics to watch

  • Digital Media net new ARR
  • Enterprise GenStudio customer adoption count

PYPLPayPal Holdings

Score: 9.3

Open ticker →

Observation

Trading at ~12.2x Forward P/E ($57) ahead of its Q3 earnings release on Tuesday, October 27. TMD growth +8.2% YoY turnaround, Fastlane guest checkout conversion lifting conversions by 80%, and $5B+ in buybacks retiring >7% of the float annually heading into peak Q4 holiday e-commerce shopping.

Catalysts to watch

  • Q3 2026 earnings release on October 27 providing an immediate fundamental catalyst
  • Fastlane enterprise scaling across Shopify and major platforms accelerating into holiday retail season
  • Venmo monetization via debit and merchant pay

Risks

  • Competition from Stripe and Apple Pay
  • Macro e-commerce consumer spending softness

Framework exit signals

  • TMD dollar growth turns negative YoY
  • Non-GAAP OPM falls below 16.5%

Metrics to watch

  • TMD growth YoY
  • Active accounts transaction volume

NKENIKE, Inc.

Score: 9.1

Open ticker →

Observation

High-conviction turnaround setup with Elliott Hill completing his first full week as CEO. Trading at a multi-decade low multiple (~18x forward P/E, -60% off peak), Nike cleared negative guidance overhang in Q1. Realignment to core performance sports innovation, wholesale retail reconciliations, and $3.8B in annual FCF provide a resilient floor.

Catalysts to watch

  • Elliott Hill driving comprehensive strategic product and wholesale reboot
  • Restoration of wholesale retail partner shelf-space across Foot Locker and specialty running doors
  • Inventory normalization paving the path for gross margin recovery in 2027

Risks

  • Greater China consumer spending recovery friction
  • Category competition from On and Hoka in performance running

Framework exit signals

  • North American wholesale order book contracts >8% YoY
  • Gross margin drops below 42.0%

Metrics to watch

  • Wholesale vs Direct-to-Consumer order velocity
  • Gross margin trajectory (%p)

CVSCVS Health

Score: 8.8

Open ticker →

Observation

High-yield turnaround compounder trading at ~10.8x forward P/E with a 3.0% dividend yield. Executive leadership transition appointing David Joyner as CEO provides immediate operational focus, Q2 Medical Benefit Ratio improved 250 bps YoY to 87.4%, and full-year CFFO is reaffirmed at $11.5B+.

Catalysts to watch

  • David Joyner CEO leadership restructuring driving healthcare operations execution
  • Multi-year Medicare Advantage margin recovery pathway
  • MinuteClinic and care delivery volume expansion

Risks

  • Medical cost utilization spikes in late 2026
  • PBM regulatory scrutiny

Framework exit signals

  • MBR exceeds 89.5% for two consecutive quarters
  • Operating margins compress >100 bps YoY

Metrics to watch

  • Health Care Benefits MBR
  • Annual operating cash flows

LENLennar Corporation

Score: 8.7

Open ticker →

Observation

Deep value dislocation at ~9.2x P/E with zero net homebuilding debt and $3.5B+ in cash reserves. Benefiting from secular structural US housing shortages, Lennar's disciplined land-light execution and targeted mortgage rate buydowns provide defensive downside safety despite rate volatility.

Catalysts to watch

  • Targeted mortgage rate buydowns sustaining high delivery volume into Q4
  • Consistent $250M quarterly share repurchase program
  • Resilient order backlogs supported by land-light balance sheet

Risks

  • Resurgent Treasury yield volatility delaying fall homebuyer traffic
  • Gross margin pressure from financing incentives

Framework exit signals

  • Homebuilding gross margin drops below 20.0%
  • Quarterly net deliveries fall >10% YoY

Metrics to watch

  • Homebuilding gross margin
  • Quarterly new orders count

Sources

AlphaSignal Research: Top 5 Undervalued US Common Stocks (Oct 24, 2026)

1. Executive Summary

Following a sharp run-up in benchmark 10-year Treasury yields to the 5.0% threshold and surging oil prices, broader equity market multiples have contracted. This macro volatility has created exceptional valuation dislocations among high-quality, cash-generative US market leaders. By screening 12 US common stocks characterized by lagging 3-month price returns despite expanding quarterly operating profitability, steady revenue growth, and robust free cash flow, we finalized the Top 5 Undervalued US Stocks offering asymmetric risk/reward over a 6 to 18 month horizon.

2. Candidate Comparison Table

  1. ADBE (Score: 9.6) | Software | 3M Return: -18.8% | Rev Growth: +10.6% | OPM Change: +1.5%p | FCF: Positive
  2. PYPL (Score: 9.3) | FinTech | 3M Return: -7.8% | Rev Growth: +8.2% | OPM Change: +1.1%p | FCF: Positive
  3. NKE (Score: 9.1) | Consumer | 3M Return: -14.8% | Rev Growth: +1.1% | OPM Change: +0.4%p | FCF: Positive
  4. CVS (Score: 8.8) | Healthcare | 3M Return: -6.2% | Rev Growth: +7.3% | OPM Change: +1.0%p | FCF: Positive
  5. LEN (Score: 8.7) | Homebuilding | 3M Return: -12.1% | Rev Growth: +7.9% | OPM Change: +0.2%p | FCF: Positive
  6. ADSK (Score: 8.5) | 7. WDC (Score: 8.4) | 8. LULU (Score: 8.2) | 9. CRM (Score: 8.0) | 10. JBHT (Score: 7.8) | 11. SBUX (Score: 7.5) | 12. INTC (Score: 6.5)

3. Top 5 Detailed Breakdown

  • ADBE (9.6): Extreme cash-flow dislocation at $240-$245 multi-year lows (EV/FCF ~10.0x, 10-year percentile <1%); post-MAX commercial Firefly ramp, generates $2.2B+ quarterly FCF ($8B+ annual run-rate) with 46% Non-GAAP OPM and active $25B buybacks retiring 29M shares YoY.
  • PYPL (9.3): P/E ~12.2x ($57), Q3 earnings catalyst on October 27, TMD +8.2% YoY turnaround, Fastlane guest checkout conversion lifting conversions by 80%, retiring >7% of shares annually via $5B+ repurchases.
  • NKE (9.1): Multi-decade valuation low (~18x P/E, -60% off peak); Elliott Hill completing first full week as CEO driving core sport innovation and wholesale shelf-space recovery, backed by $3.8B in annual FCF.
  • CVS (8.8): P/E ~10.8x, 3.0% dividend yield, David Joyner appointed CEO to accelerate operational healthcare restructuring, Q2 MBR improved 250 bps YoY to 87.4%, CFFO guidance reaffirmed at $11.5B+.
  • LEN (8.7): P/E ~9.2x with zero net homebuilding debt and $3.5B+ cash reserves; targeted rate buydowns and chronic US housing shortages provide strong downside floor.

4. Conclusion

  • Highest Conviction: ADBE
  • Best Immediate Earnings Catalyst: PYPL
  • Best Turnaround Catalyst: NKE
  • Best Management Catalyst: CVS
  • Best Balance Sheet & Value: LEN
  • Watchlist: ADSK, WDC, LULU, CRM

Not investment advice. Scores and lists are relative snapshots.

← All notes